Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Johnson David Michael Insider Profile
4 Followers
Johnson David Michael, Director at Zentalis Pharmaceuticals, holds 110.65K shares in Zentalis Pharmaceuticals (Ticker: ZNTL).
Johnson David Michael has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Johnson David Michael's holdings
Insider Roles
Director
Roles that Johnson David Michael holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Johnson David Michael
Johnson David Michael's Trading History
List of latest transactions for each holding click on a transaction to see Johnson David Michael's performance on stock
You May Also Like
Johnson David Michael insider profile FAQ
What is the percentage of profitable transactions made by Johnson David Michael?
The percentage of profitable transactions made by Johnson David Michael is ―.
What is the average return per transaction made by Johnson David Michael?
The average return per transaction made by Johnson David Michael is ―.
What stocks does Johnson David Michael hold?
Johnson David Michael holds: ZNTL stocks.
What was Johnson David Michael’s latest transaction?
Johnson David Michael latest transaction was an Uninformative Buy of ―.
What was Johnson David Michael's most profitable transaction?
Johnson David Michael’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Johnson David Michael's role in Zentalis Pharmaceuticals?
Johnson David Michael's role in Zentalis Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.